Navigation Links
Results of new exploratory analyses assessing the incidence of hypoglycemia with linagliptin in adults with type 2 diabetes announced
Date:6/22/2013

about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim has a demonstrated commitment to corporate social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about $19.1 billion (14.7 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 22.5 percent of its net sales.

For more information please visit www.us.boehringer-ingelheim.com

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in '/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
2. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
3. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
4. National Brain Tumor Society Responds to Results of Avastin Clinical Trials
5. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
6. GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results
7. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
8. The Renewable Corporation (RNWB) through its wholly owned subsidiary EcoSmart Surface & Coating Technologies receives results from Product Test Service.
9. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
10. Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
11. Cempra Presents Post-Phase 2 Analysis of Solithromycins Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... MA (PRWEB) September 30, 2014 ... SoundConnect announces four new-hosted collaboration bundles ... bundles deliver high quality conferencing experiences for low, ... packages to choose from, businesses have optimized solutions ... bundled solutions include audio only minutes (1K, ...
(Date:10/1/2014)... Industry leaders from retail pharmacies to ... theme, ,Commercial Opportunities in the Era of Reform, from ... Elsevier , a world-leading provider of scientific, technical and ... of some of the industry,s most prominent healthcare leaders ... in the future. The Elsevier Healthcare and ...
(Date:9/30/2014)... , Sept. 30, 2014 Pacific ... 2014 Summary Global Markets Direct,s, ,Pacific ... 2014, provides an overview of the Pacific Northwest ... This report provides comprehensive information on the current ... complete with comparative analysis at various stages, therapeutics ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
Breaking Biology Technology:SoundConnect Launches New Audio, Web and Video Bundles 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3
... 4, 2011 The ALS Therapy Development ... Godhwani, a successful Silicon Valley entrepreneur, to its board ... organization with a mission to discover and develop treatments ... Lou Gehrig,s Disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ...
... LAS VEGAS, Feb. 4, 2011 Cord Blood America, ... CBAI ), the umbilical cord blood stem cell preservation ... stem cells to families nationwide and internationally, announced today that ... and international cell and tissue bank to provide placenta, umbilical ...
... Codexis, Inc. (Nasdaq: CDXS ) today announced ... December 31, 2010.   Full Year ... driven by a 77% increase in sales of pharmaceutical ... in 2010, and increases in collaborative R&D and government ...
Cached Biology Technology:ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors 2Cord Blood America Announces Second Supply Agreement to Provide Placenta, Umbilical Cord Collection Services to Major Tissue Bank 2Codexis Reports Fourth Quarter and Full Year 2010 Results 2Codexis Reports Fourth Quarter and Full Year 2010 Results 3Codexis Reports Fourth Quarter and Full Year 2010 Results 4Codexis Reports Fourth Quarter and Full Year 2010 Results 5Codexis Reports Fourth Quarter and Full Year 2010 Results 6Codexis Reports Fourth Quarter and Full Year 2010 Results 7Codexis Reports Fourth Quarter and Full Year 2010 Results 8
(Date:10/1/2014)... TURKU , Finnland, October 1, 2014 ... der Durchbruch im Bereich der Biowissenschaften   ... Jahren ein Kommen und Gehen zahlreicher Detektionstechnologien. ... sich zum goldenen Standard. Die Photonen-Upconversion ist ... den letzten Jahren mit Begeisterung aufgenommen wurde. ...
(Date:9/30/2014)... at the University of California, San Diego, have completed ... using a method that uses the pixels in an ... known as mesh-free simulation. , The researchers, led by ... at the Jacobs School of Engineering at UC San ... method at the CompIMAGE,14 conference in Pittsburgh this month. ...
(Date:9/30/2014)... Institutes of Health (NIH) awarded Lawrence Livermore National ... electrode array system that will enable researchers to ... resolution and scale. , LLNL,s grant-funded project is ... BRAIN (Brain Research through Advancing Innovative Neurotechnologies) ... our understanding of the human mind and uncover ...
Breaking Biology News(10 mins):Innovative Verwendungslösung für die Photonen-Upconversion 2Innovative Verwendungslösung für die Photonen-Upconversion 3First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
... time in its history, the American Society for Cell Biology ... the ASCB,s Annual Meeting, for "An Evening of Art & ... Dec. 15. Members of the public who sign ... complimentary registration to the ASCB keynote addresses by Stephen Chu, ...
... into a previously unknown structure in between a liquid ... containing long oily chains, according to Purdue University researchers. ... Water plays a huge role in biological processes, ... be that this transformation is useful in a way ...
... Missouri researcher Mark Flinn, professor of anthropology, has been ... of Science fellow for his "theoretical contributions in the ... pioneering field research on stress response, family environment, and ... Election as a fellow of the AAAS ...
Cached Biology News:Public invited to 'An Evening of Science & Art' at ASCB Annual Meeting 2Oil and water: An icy interaction when oil chains are short, but steamy when chains are long 2Oil and water: An icy interaction when oil chains are short, but steamy when chains are long 3Cultural anthropologist Mark Flinn named 2013 AAAS Fellow 2
... Free Epitope Design consultation. Peptide synthesis ... amino acids). Conjugation to KLH. ... Immunization of 2 New Zealand white female ... immunizations and 4 production bleeds. Elisa ...
Request Info...
... 5 barrel liners, 5 white cartridge holders, cartridge ... gene gun is a convenient, hand-held device that ... range of targets in vivo. The unit uses ... or RNA-coated gold microcarriers from the inner wall ...
Intestinal Epithelium Differentiation Environment...
Biology Products: